ECL
55
-7
GILD
52
2
SLG
45
-3
AN
61
9
O
57
2
UHS
66
-5
NTAP
65
-2
DAL
79
2
V
42
-2
TRV
56
7
NSC
64
2
GOOG
69
2
ORLY
49
-3
F
59
3
XOM
64
8
CTSH
63
3
R
72
5
VMC
59
3
LB
46
15
AMG
77
2
ECL
55
-7
GILD
52
2
SLG
45
-3
AN
61
9
O
57
2
UHS
66
-5
NTAP
65
-2
DAL
79
2
V
42
-2
TRV
56
7
NSC
64
2
GOOG
69
2
ORLY
49
-3
F
59
3
XOM
64
8
CTSH
63
3
R
72
5
VMC
59
3
LB
46
15
AMG
77
2
Financhill
Back

Guardant Health, Inc. Stock Predictions

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
53

GH
Guardant Health, Inc.

Last Price:
$108.51
Seasonality Move:
-2.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Guardant Health, Inc. Stock Forecast

  • Over the next 52 weeks, Guardant Health, Inc. has on average historically risen by 34.3% based on the past 7 years of stock performance.
  • Guardant Health, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Guardant Health, Inc. Stock Undervalued?
    The current Guardant Health, Inc. [GH] share price is $108.52. The Score for GH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • GH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Guardant Health, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Guardant Health, Inc. has on average historically risen by 34.3% based on the past 7 years of stock performance.

Guardant Health, Inc. Stock Rating

Buy
53
Guardant Health, Inc. (GH) is a Buy

Is Guardant Health, Inc. overpriced?

  • Guardant Health, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Guardant Health, Inc. Stock Price History

Is GH stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GH is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
guardanthealth.com

52-Week Data

52-Week High:
112.43
52-Week Low:
29.91

Prediction Charts

Market Cap:
14.1B
Price in USD:
108.52
Volume:
1.9M
Beta:
1.12

Technical Analysis

SMA50:
82.88
SMA100:
68.79
SMA200:
56.77
52-Wk Change:
184.75%

Stock Predictions

  • Is Guardant Health, Inc. stock public?
    Yes, Guardant Health, Inc. is a publicly traded company.
  • What is the Guardant Health, Inc. stock quote today?
    The Guardant Health, Inc. stock price is 108.52 USD today.
  • How to buy Guardant Health, Inc. stock online?
    You can buy Guardant Health, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-14 91.21 94.37 95.78 90.44
Nov-17 94.49 96.48 97.45 93.98
Nov-18 95.84 95.57 97.67 94.05
Nov-19 95.88 99.55 105.27 95.01
Nov-20 103.50 100.30 110.00 100.04
Nov-21 99.75 105.42 108.06 98.23
Nov-24 105.79 111.25 111.91 104.35
Nov-25 112.43 108.81 112.43 108.52
Nov-26 108.76 107.79 109.81 106.67
Nov-28 108.81 108.42 108.81 106.48
Dec-1 107.92 105.22 108.13 104.57
Dec-2 106.62 103.87 107.47 103.36
Dec-3 104.45 105.96 107.19 103.47
Dec-4 106.01 108.52 109.59 105.68

Guardant Health, Inc. Earnings

Guardant Health, Inc. Earnings Report: Per Share Guardant Health, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Guardant Health, Inc. Forecast Revenue Growth

Guardant Health, Inc. Stock Analysis: Historical quarterly revenues per share for Guardant Health, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.36 per share.

* Guardant Health, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.